US Patent Issued to ALCHEMEDICINE on Dec. 30 for "Compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug" (Japanese Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,509,423, issued on Dec. 30, was assigned to ALCHEMEDICINE INC. (Ibaraki, Japan).

"Compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug" was invented by Keigo Tanaka (Tsukuba, Japan) and Tomohisa Ninomiya (Tsukuba, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound and so on having aldehyde dehydrogenase 2 (ALDH2) activation effect. A compound, a pharmaceutically acceptable salt of the compound, or a prodrug of the compound or the salt, the compound being represented by the following formula (1):wherein A is a heterocycle, R1 and R2 are each independently hydrog...